Showei Pharmaceutical will dispose of 7,500 shares of treasury stock on August 17, 2026, raising a total of 12,412,500 yen. This is part of a stock compensation program aimed at incentivizing targeted directors.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3537","jir_company_name":"Showei Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3537-20260717-01.pdf","jir_short_summary":"Showei Pharmaceutical will dispose of 7,500 shares of treasury stock on August 17, 2026, raising a total of 12,412,500 yen. This is part of a stock compensation program aimed at incentivizing targeted directors.","jir_summary":"### Summary of Disposal\nShowei Pharmaceutical, as part of its restricted stock compensation system, disposed of 7,500 shares of treasury stock to three targeted directors, raising a total of 12,412,500 yen. The payment price per share is 1,655 yen, based on the market stock price. The disposal is scheduled for August 17, 2026, aiming to minimize shareholder stock dilution and to incentivize directors. The system includes provisions for a restricted transfer period and conditions for\u89e3\u9664, contingent on continuous service by directors. This initiative seeks to enhance long-term corporate value.\n\n### Impact on Shareholders and Future Outlook\nThis disposal of treasury stock aims to minimize shareholder dilution while reinforcing directors' commitment to increasing corporate value. The funds raised will likely be used for future business investments and growth strategies. The system is designed to align incentives and share value with shareholders, contributing to long-term improvement in corporate value. Continuous monitoring of system implementation and its impact on performance remains essential.","jir_financial_highlights":"Number of shares disposed: 7,500 shares (Unknown)\nDisposal amount: 12,412,500 yen (Unknown)\nPayment price (stock price): 1,655 yen (Unknown)","jir_category":"","jir_hashtags":"#ShoweiPharmaceutical, #ShareBuyback, #JapanStock","jir_key_figures":"Number of shares disposed: 7,500 shares\nDisposal amount: 12,412,500 yen\nPayment price (stock price): 1,655 yen","jir_meta_title":"\u3010Showei Pharmaceutical\u3011Share Buyback of Restricted Stock Compensation\uff5cJuly 2026","jir_meta_description":"Showei Pharmaceutical will dispose of 7,500 shares of treasury stock in August 2026, raising 12.41 million yen. Part of an officer incentive program.","jir_og_title":"\u3010Showei Pharmaceutical\u3011Share Disposal\uff5cJuly 2026","jir_og_description":"Showei Pharmaceutical will disposal of 7,500 shares of treasury stock to implement an officer incentive scheme and raise funds.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59899,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-82373","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n